Heidi Cuthbert - Author on Grafa

Bitcoin rebounded about 4.78% to trade near $69,128 after opening around $65,974, but technical signals suggest the broader market structure still favours bears.

Global biotechnology firm CSL (ASX:CSL) has broken ground on a $1.5 billion expansion of its manufacturing facility in Kankakee.

Precision BioSciences (NASDAQ:DTIL) shares are in focus after the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD, an investigational in vivo gene editing therapy designed to treat Duchenne muscular dystrophy (DMD).

American Express Global Business Travel (NYSE:GBTG) reported a transformative fourth quarter on Monday, as the integration of recent acquisition CWT propelled revenue up 34% to $792 million.

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) reported a fourth-quarter loss that was narrower than analysts anticipated, bolstered by a significant cash injection and clinical progress in its high-priority obesity and oncology programs.

3D Systems (NYSE:DDD) reported a fourth-quarter loss that underscored the ongoing volatility in the industrial manufacturing sector, even as the company saw a double-digit jump in sequential sales.

Pfizer announced positive topline results for its investigational trispecific antibody, tilrekimig, which demonstrated significant skin clearance in adults with moderate to severe eczema and paved the way for a pivotal Phase 3 study later this year.

IDEAYA Biosciences reached a key clinical milestone on Monday, dosing the first patient in its Phase 1 trial for IDE892, a potential best-in-class PRMT5 inhibitor designed to target MTAP-deleted solid tumors.

XRP investors are currently holding approximately $50.8 billion in unrealised losses after the token’s sharp decline from its 2025 peak, according to blockchain analytics firm Glassnode.

Fortescue (ASX:FMG) has broke ground on the 440MW Solomon Airport solar farm, set to be WA’s largest by 2028.